NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Health / Surgery
Written by / Agency / Source: Frost & Sullivan
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Government Support for Improved Disease Management Fuels the Indonesian Infectious Disease IVD Market Finds Frost & Sullivan - Higher private investments help meet the innovation needs of th infectious disease IVD market - LifeSciences.Frost.com
Government Support for Improved Disease Management Fuels the Indonesian Infectious Disease IVD Market Finds Frost & Sullivan

 

NewswireToday - /newswire/ - Jakarta, Indonesia, 2014/06/20 - Higher private investments help meet the innovation needs of th infectious disease IVD market - LifeSciences.Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The infectious disease market is one of the largest segments of the in-vitro diagnostics (IVD) market in Indonesia, accounting for approximately 62 percent of the total market. Increased incidence of infectious diseases such as hepatitis C, HIV, TB, malaria and dengue have spurred the government to invest strongly in primary healthcare system, public hospital reforms, promotion of IVD-related technology innovation among local participants, and improved reimbursement policy, thus creating a favorable climate for market participants.

New analysis from Frost & Sullivan, Indonesian Infectious Disease IVD Market, finds that the market earned revenues of $38.6 million revenue in 2013, which is expected to reach $59.9 million in 2017. The market is segmented into immunochemistry testing, microbiology testing, and molecular diagnostics testing. Among these, the molecular diagnostics segment, which includes virology, bacteriology, molecular blood donor screening and genetic testing, is expected to grow the fastest.

Despite the strong government backing, Indonesia’s infectious disease IVD market is battling a shortage of skilled healthcare workers and laboratory facilities. This issue hampers the accurate identification, diagnosis and reporting of infectious diseases in the country.

The market is further pegged back by the long turnaround times of tests and high level of investments needed. These challenges, however, are opportunities for companies in the opposite ends of the spectrum.

"The domestic participants in the low-end market will have an edge due to their competitive pricing and faster turnaround time," explains Frost & Sullivan Healthcare Research Analyst Sanjeev Kumar. "Meanwhile, multinational companies (MNCs) in the high-end market can meet various end-user demands by offering improved localized service."

This scenario is ideal to foster partnerships between multinational companies and local participants. Collaborations between the two will create a symbiotic ecosystem, wherein local companies will gain access to capital, technology and intellectual property, and MNCs will benefit from the market reach of the domestic companies.

"Furthermore, the rise in private funding has paved the way for innovations in the Indonesia’s infectious disease IVD market," noted Kumar. "Manufacturers are already developing analyzers to meet end-user budgets, test volumes, desired breadth of test panels, and levels of automation."

The adoption of new technologies will go a long way in enhancing the patient care. For instance, highly automated analyzers with automated sample-handling features and sophisticated informatics will improve throughput and eventually, diagnostic results.

If you are interested in more information on this study, please send an email to Donna Jeremiah, Corporate Communications, at djeremiah[.]frost.com, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.

Indonesian Infectious Disease IVD Market is part of the Life Sciences (lifesciences.frost.com) Growth Partnership Service program. Frost & Sullivan’s related studies include: Pulse of Telehealth 2013, the Global Emerging Interventional Cardiac Devices Market, Disinfection and Sterilization Equipment Market Trends in Asia-Pacific, and the Accountable Care Team: A Guide for Care Delivery Transformation. All studies included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion | Join Us: Join our community | Subscribe: Newsletter on "the next big thing" | Register: Gain access to visionary innovation

Indonesian Infectious Disease IVD Market / P7F9-52

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Government Support for Improved Disease Management Fuels the Indonesian Infectious Disease IVD Market Finds Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Donna Jeremiah - Frost.com 
+61(2) 8247 8927 djeremiah[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Health / Surgery Most Recent Related Newswires:

InterSystems Partners with the Rhodes Group to Improve Hepatitis C Treatment in New Mexico
BostonGene Announces 0 Million Series B Funding at a Multi-Billion Dollar Valuation, Propelling the Company to Unicorn Status
Research Grant Awarded for Low-Grade Ovarian Cancer Study
Roche Diagnostics India Earns the Frost & Sullivan 2021 India Competitive Strategy Leadership Award
Wolters Kluwer Lauded by Frost & Sullivan for Enabling Aligned Decision-making with its Clinical Decision Support Solutions
Syapse Awarded 2021 Technology Innovation Leadership Award by Frost & Sullivan for Accelerating Real-world Care Delivery
Lumeon Commended by Frost & Sullivan for Enabling Digital Transformation in Healthcare
Payment Integrity Solutions Enable Healthcare Plans to Optimize Processes and Maximize Returns Finds Frost & Sullivan
Menopause to Become the Next Game-changer in the Global Femtech Solutions Industry by 2025 Finds Frost & Sullivan
Innovative MedTech Business Models Will Enable Cost-effective, Decentralized and Patient-centric Care Finds Frost & Sullivan
Data Monetization a Must for MedTech Industry to Evolve Toward Real-World Evidence and Precision Medicine Finds Frost & Sullivan
InterSystems Partners with Cognetivity on Ground-breaking AI Solution for Early Dementia Detection
Humimic Medical, Partners Team Up to Make A Difference in South Carolina COVID Battle
Adoption of HaH Model Surged Eight-fold with the Availability of Advanced Remote Monitoring and Digital Health Solutions Finds Frost & Sullivan
Major Innovation Announcement Planned, SC Life Sciences Conference Shatters Registration Record

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  JobsWare.com





 
  ©2022 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)